Benzinga's Top Downgrades
Analysts at BMO Capital downgraded The Fresh Market Inc (NASDAQ: TFM) from Outperform to Market Perform. The target price for Fresh Market has been lowered from $44 to $28. Fresh Market shares closed at $29.61 on Friday.
Pacific Crest downgraded YY Inc (ADR) (NASDAQ: YY) from Overweight to Sector Weight and removed the price target of $80.00. YY shares closed at $61.02 on Friday.
Summit Research downgraded NetApp Inc. (NASDAQ: NTAP) to Sell. The target price for NetApp has been lowered from $32 to $28. NetApp shares closed at $30.75 on Friday.
Analysts at Wedbush downgraded Micron Technology, Inc. (NASDAQ: MU) from Outperform to Neutral. The target price for Micron Technology has been lowered from $26 to $19. Micron Technology shares closed at $16.95 on Friday.
Piper Jaffray downgraded Texas Capital Bancshares Inc (NASDAQ: TCBI) from Overweight to Neutral. The target price for Texas Capital Bancshares has been lowered from $66.50 to $61. Texas Capital Bancshares shares closed at $57.23 on Friday.
Analysts at Goldman Sachs downgraded Cytec Industries Inc (NYSE: CYT) from Buy to Neutral. The target price for Cytec Industries has been lowered from $69 to $68. Cytec Industries shares closed at $74.16 on Friday.
Baird downgraded Summit Midstream Partners LP (NYSE: SMLP) from Outperform to Neutral. The target price for Summit Midstream Partners has been lowered from $39 to $26. Summit Midstream Partners shares closed at $25.03 on Friday.
Analysts at Cowen & Company downgraded Copa Holdings, S.A. (NYSE: CPA) from Outperform to Market Perform. The target price for Copa Holdings has been lowered from $110 to $60. Copa Holdings shares closed at $62.01 on Friday.
Latest Ratings for TFM
Date | Firm | Action | From | To |
---|---|---|---|---|
Apr 2016 | Terminates | Neutral | ||
Apr 2016 | Downgrades | Overweight | Equal-Weight | |
Mar 2016 | Upgrades | Underweight | Equal-Weight |
View More Analyst Ratings for TFM
View the Latest Analyst Ratings
Posted-In: Top DowngradesDowngrades Analyst Ratings
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.